| Abstrakt: |
Helius Medical Technologies, Inc. (TSX:HSM, and HSM.W and OTCQB:HSDT) ("Helius" or the "Company") announced today that it has been issued its first method patent (U.S. Patent No. 9,656,069) that features claims directed to the use of the PoNS™ device for human performance improvement rather than rehabilitation therapy. The ‘069 patent is the first member of the existing family of patents the company has received for its core asset, the PoNS device, in the field of human performance improvement. Potential uses could include supporting physical and cognitive improvements in healthy adults, or more leisurely pursuits such as improving a golf-swing. This recent patent further reinforces the current family of PoNS patents protecting various forms of physical and cognitive therapy in combination with both skin and oral cavity stimulation using the PoNS device or any equivalent neurostimulation device that the company may develop. [ABSTRACT FROM PUBLISHER] |
